Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “oxygen”

78 pharma patents match "oxygen" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 78
Index total 30,257
Page 2 / 4

Quick answer

This filtered view shows 78 pharmaceutical patents matching "oxygen" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

78 results for “oxygen” · 30,257 patents in full index Clear search

  1. US 10080740

    Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Aurigene Discovery Technologies Limited · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  2. US 9993765

    Portable oxygen enrichment device and method of use

    SEPARATION DESIGN GROUP LLC · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted

  3. US 9937155

    Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Aurigene Discovery Technologies Limited · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  4. US 9839690

    Singlet oxygen-labile linkers and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted

  5. US 9750849

    Oxygen generating biomaterial

    The Board of Regents of the University of Texas System · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted

  6. US 9663790

    Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted May 30, 2017 · Expires May 25, 2037

    granted

  7. US 9630932

    Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Aurigene Discovery Technologies Limited · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  8. US 9499497

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

    Vertex Pharmaceuticals Incorporated · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  9. US 9493526

    Compositions and methods for the delivery of oxygen

    The Regents of the University of California · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  10. US 9492781

    Portable oxygen enrichment device and method of use

    SEPARATION DESIGN GROUP LLC · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  11. US 9433666

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted

  12. US 9393306

    Singlet oxygen-labile linkers and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  13. US 9114151

    Method for modulating or controlling sodium channel current by reactive oxygen species (ROS) originating from mitochondria

    THE UNITED STATES OF AMERICA DEPT. OF VETERANS AFFAIRS · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  14. US 9073875

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

    Vertex Pharmaceuticals Incorporated · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  15. CA 2866861

    TRAITEMENT DES MIGRAINES CHRONIQUES PAR INHALATION D'OXYGENE

    AIR LIQUIDE SANTE INT [FR] · Granted May 26, 2015 · Expires May 21, 2035

    granted

  16. US 9018210

    Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation

    The Regents of the University of California · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  17. US 8888902

    Portable oxygen enrichment device and method of use

    SEPARATION DESIGN GROUP LLC · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted

  18. US 8883189

    Intraocular encapsulation of oxygenic bacteria

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  19. US 8841295

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Panmira Pharmaceuticals, LLC · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  20. US 8772495

    5-lipoxygenase-activating protein inhibitor

    Panmira Pharmaceuticals, LLC · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted

  21. US 8710081

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Panmira Pharmaceuticals, LLC · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  22. US 8697730

    5-lipoxygenase activating protein (FLAP) inhibitor

    Panmira Pharmaceuticals, LLC · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  23. US 8580844

    Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities

    Georgia Regents Research Institute, Inc. · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted

  24. US 8455437

    Method to predict and prevent oxygen-induced inflammatory tissue injury

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.